The efficacy and safety of crizotinib in patients with ROS1 positive advanced stage NSCLC: The real-world experience from Turkey

Kilickap, S.Olmez, O. F.Cicin, I.Demirci, U.Alan, O.Cabuk, D.Sakalar, T.2024-06-122024-06-1220180923-75341569-8041https://hdl.handle.net/20.500.14551/2680743rd ESMO Congress (ESMO) -- OCT 19-23, 2018 -- Munich, GERMANY[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keywords]The efficacy and safety of crizotinib in patients with ROS1 positive advanced stage NSCLC: The real-world experience from TurkeyConference Object29505505Q1WOS:000459277303171